Production (Stage)
Bone Biologics Corporation
BBLG
$5.08
$0.142.83%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -17.40% | -6.77% | 52.93% | -27.75% | 6.64% |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -25.77% | 144.68% | -46.14% | -25.43% | -25.97% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -19.02% | -33.08% | -40.69% | 97.78% | 0.00% |
Total Current Assets | -18.11% | -5.03% | 27.31% | -16.83% | 2.72% |
|
|||||
Total Current Assets | -18.11% | -5.03% | 27.31% | -16.83% | 2.72% |
Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | -18.11% | -5.03% | 27.31% | -16.83% | 2.72% |
|
|||||
Total Accounts Payable | -33.57% | 96.21% | -18.03% | 58.62% | -59.47% |
Total Accrued Expenses | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | -29.79% | -94.36% | 58.37% | 185.87% | -96.09% |
Total Other Current Liabilities | -29.79% | -94.36% | 58.37% | 185.87% | -96.09% |
Total Current Liabilities | -33.49% | 38.15% | -3.90% | 72.84% | -80.20% |
|
|||||
Total Current Liabilities | -33.49% | 38.15% | -3.90% | 72.84% | -80.20% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | -33.49% | 38.15% | -3.90% | 72.84% | -80.20% |
|
|||||
Common Stock & APIC | 0.50% | 1.39% | 2.13% | 0.02% | 1.95% |
Retained Earnings | -1.20% | -1.82% | -1.14% | -0.96% | -1.07% |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | -16.44% | -8.14% | 30.37% | -20.84% | 26.44% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -16.44% | -8.14% | 30.37% | -20.84% | 26.44% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -16.44% | -8.14% | 30.37% | -20.84% | 26.44% |
|